Bavarian Nordic A/S (OTCMKTS:BVNRY – Get Free Report) shares crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $10.13 and traded as low as $7.87. Bavarian Nordic A/S shares last traded at $8.05, with a volume of 7,983 shares trading hands.
Bavarian Nordic A/S Price Performance
The business has a 50 day simple moving average of $8.98 and a 200 day simple moving average of $10.13. The company has a market cap of $1.90 billion, a price-to-earnings ratio of 11.67 and a beta of 1.68.
About Bavarian Nordic A/S
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.
Featured Stories
- Five stocks we like better than Bavarian Nordic A/S
- Health Care Stocks Explained: Why You Might Want to Invest
- 3 Must-Have ETFs Set to Dominate This Quarter
- What Are the FAANG Stocks and Are They Good Investments?
- Seeking Stability? These 3 Stocks Offer Strong Potential
- How to Use the MarketBeat Excel Dividend Calculator
- Trade War Bargain Stocks: Top 3 Picks Too Good to Pass Up
Receive News & Ratings for Bavarian Nordic A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bavarian Nordic A/S and related companies with MarketBeat.com's FREE daily email newsletter.
